Open AccessAn In-silico Study: Investigating the Blockade Mechanism of Therapeutic Antibody Durvalumab
Publication year - 2021
Language(s) - English
Resource type - Conference proceedings
DOI - 10.18178/wcse.2021.06.019
Subject(s) - durvalumab , mechanism (biology) , in silico , blockade , computer science , antibody , computational biology , medicine , biology , immunology , immune system , immunotherapy , genetics , receptor , epistemology , nivolumab , gene , philosophy